CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Primary Amoebic Meningoencephalitis (PAM) is caused by Naegleria fowleri, a free-living amoeba that occasionally infects humans. While considered "rare" (but likely underreported) the high mortality rate and lack of established success in treatment makes PAM a particularly devastating infe...
Furkejuvvon:
Váldodahkkit: | Anjan Debnath (Dahkki), Claudia M Calvet (Dahkki), Gareth Jennings (Dahkki), Wenxu Zhou (Dahkki), Alexander Aksenov (Dahkki), Madeline R Luth (Dahkki), Ruben Abagyan (Dahkki), W David Nes (Dahkki), James H McKerrow (Dahkki), Larissa M Podust (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Public Library of Science (PLoS),
2017-12-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds.
Dahkki: Conall Sauvey, et al.
Almmustuhtton: (2021) -
Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment
Dahkki: Javier Chao-Pellicer, et al.
Almmustuhtton: (2023) -
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
Dahkki: Shamila S Gunatilleke, et al.
Almmustuhtton: (2012) -
Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China
Dahkki: Wenjuan Zhou, et al.
Almmustuhtton: (2022) -
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
Dahkki: Chiung-Kuang Chen, et al.
Almmustuhtton: (2010)